|
|
|
|
Alkermes' Corporate Presentation to be Webcast at the Jefferies & Company 3rd Annual Healthcare Conference
Alkermes, Inc.is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL for alcohol dependence and...
|
|
|
Alkermes' Corporate Presentation to be Webcast at the Jefferies & Company 3rd Annual Healthcare Conference
CAMBRIDGE, Mass.- (BUSINESS WIRE) - Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Jefferies & Company on Wednesday, June 17, 2009, at 2:00 p.m. ET from New York City. The...
|
|
|
Alkermes' Corporate Presentation to be Webcast at the Jefferies & Company 3rd Annual Healthcare Conference
- Alkermes, Inc.(NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Jefferies & Company on Wednesday, June 17, 2009, at 2:00 p.m. ET from New York City. The presentation may be accessed under...
|
|
|
Alkermes' Corporate Presentation to be Webcast at the Jefferies &
Alkermes, Inc.ALKS announced today that its corporate presentation will be webcast live by Jefferies & Company on Wednesday, June 17, 2009, at 2:00 p.m. ET from New York City. The presentation may be accessed under the investor...
|
|
|
Alkermes' Corporate Presentation to be Webcast at the Jefferies & Company 3rd Annual Healthcare Conference
Alkermes, Inc.(NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Jefferies & Company on Wednesday, June 17, 2009, at 2:00 p.m. ET from New York City. The presentation may be accessed under the...
|
|
|
Alkermes' Corporate Presentation to be Webcast at the Jefferies & Company 3rd Annual Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc.(NASDAQ: ALKS - News) announced today that its corporate presentation will be webcast live by Jefferies & Company on Wednesday, June 17, 2009, at 2:00 p.m. ET from New York City.
|
|
|
Alkermes' Corporate Presentation to be Webcast at the Jefferies & Company 3rd Annual Healthcare Conference
Alkermes, Inc.is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL for alcohol dependence and...
|
|
|
Alkermes Outlook Remains Bleak
You are currently following Zacks.com You are no longer following Zacks.com By: Grant Zeng, CFA Alkermes Inc.(ALKS) Total revenues for the quarter ended March 31, 2009 were $43.9 million, down 30% compared to $62.4 million for the same...
|
|
|
Alkermes Outlook Remains Bleak
Highlights include Alkermes Inc.(NasdaqGS: ALKS - News), Johnson & Johnson (NYSE: JNJ - News), Eli Lilly & Co. (NYSE: LLY - News) and Cephalon Inc. (NasdaqGS: CEPH - News).Fiscal 4th quarter 2009 financial performance...
|
|
|
Alkermes' Corporate Presentation to be Webcast at the Deutsche Bank 34th Annual Health Care Conference
Alkermes, Inc.is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL for alcohol dependence and...
|
|
|
Alkermes to Host Conference Call to Discuss Fiscal Year 2009 Financial Results
The conference call will be webcast on the investor relations section of Alkermes' website at www.alkermes.com or may be accessed by dialing 1-866-256-9239 for domestic callers and 1-703-639-1213 for international callers.The conference...
|
|
|
Alkermes' Corporate Presentation to be Webcast at the Deutsche Bank 34th Annual Health Care Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc.(NASDAQ: ALKS - News) announced today that its corporate presentation will be webcast live by Deutsche Bank on Monday, May 18, 2009, at 9:20 a.m. The presentation will be webcast from the...
|
|
|
Alkermes' Corporate Presentation to be Webcast at Two Upcoming Investor Conferences
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc.(NASDAQ: ALKS - News) announced today that its corporate presentation will be webcast live by Bank of America and Merrill Lynch on Wednesday, May 13, 2009, at 12:40 p.m. ET from New York...
|
|
|
Alkermes Signs Lease for New Headquarters in Waltham, Massachusetts
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc.(NASDAQ: ALKS - News) today announced plans to move its corporate headquarters to Waltham, Massachusetts from Cambridge, Massachusetts. In connection with the move, the company has signed...
|
|
|
Alkermes Signs Lease for New Headquarters in Waltham, Massachusetts
Company Website: http:www.alkermes.comCAMBRIDGE, Mass.-- (Business Wire) Alkermes, Inc. (NASDAQ: ALKS) today announced plans to move its corporate headquarters to Waltham, Massachusetts from Cambridge, Massachusetts. In connection...
|
|
|
Alkermes Completes Enrollment for Registration Study of VIVITROL in Patients with Opioid Dependence
Alkermes also announced today that the company is expanding its VIVITROL clinical development program for the treatment of opioid dependence and will initiate a phase 3b study in healthcare professionals, such as physicians, nurses or...
|
|
|
Alkermes Completes Enrollment for Registration Study of VIVITROL in Patients with Opioid Dependence
_ Alkermes Completes Enrollment for Registration Study of VIVITROL in Patients with Opioid Dependence.
|
